Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001599901-25-000071
Filing Date
2025-03-21
Accepted
2025-03-21 18:40:25
Documents
1
Period of Report
2025-03-20

Document Format Files

Seq Description Document Type Size
1 FORM 4 wk-form4_1742596819.html 4  
1 FORM 4 wk-form4_1742596819.xml 4 4573
  Complete submission text file 0001599901-25-000071.txt   6289
Mailing Address 10578 SCIENCE CENTER DRIVE SUITE 125 SAN DIEGO CA 92121
Business Address 10578 SCIENCE CENTER DRIVE SUITE 125 SAN DIEGO CA 92121 858-401-7900
Avidity Biosciences, Inc. (Issuer) CIK: 0001599901 (see all company filings)

EIN.: 461336960 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O AVIDITY BIOSCIENCES, INC. 10578 SCIENCE CENTER DR., SUITE 125 SAN DIEGO CA 92121
Business Address
Flanagan W. Michael (Reporting) CIK: 0001841990 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-39321 | Film No.: 25761884